Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
Website:
http://www.rapportrx.comNext earnings report:
29 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 16 Sep 2024 20:00:11 GMTDividend
Analysts recommendations
Institutional Ownership
RAPP Latest News
Veuillez trouver ci-joint le rapport annuel Pilier 3 au 30 juin 2024 Attachment Rapport semestriel Pilier 3 - 30 juin 2024
BOSTON and SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders, today announced presentations at two upcoming medical conferences: the International League Against Epilepsy (ILAE) 15th Annual European Epilepsy Congress (EEC) in Rome, Italy, September 7-11, 2024, and the 2024 Epilepsy Foundation Pipeline Conference in Atlanta, Ga., September 25-26, 2024.
What type of business is Rapport Therapeutics?
Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts.
What sector is Rapport Therapeutics in?
Rapport Therapeutics is in the Healthcare sector
What industry is Rapport Therapeutics in?
Rapport Therapeutics is in the Biotechnology industry
What country is Rapport Therapeutics from?
Rapport Therapeutics is headquartered in United States
What is Rapport Therapeutics website?
https://www.rapportrx.com
Is Rapport Therapeutics in the S&P 500?
No, Rapport Therapeutics is not included in the S&P 500 index
Is Rapport Therapeutics in the NASDAQ 100?
No, Rapport Therapeutics is not included in the NASDAQ 100 index
Is Rapport Therapeutics in the Dow Jones?
No, Rapport Therapeutics is not included in the Dow Jones index
When was Rapport Therapeutics the previous earnings report?
No data
When does Rapport Therapeutics earnings report?
The next expected earnings date for Rapport Therapeutics is 29 November 2024